|
Volumn 161, Issue 1, 2004, Pages 175-
|
Clozapine Therapy during Cancer Treatment [1]
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CLOZAPINE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
NEUROLEPTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
ADULT;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CASE REPORT;
FEMALE;
HUMAN;
LETTER;
LEUKOPENIA;
MASTECTOMY;
MENTAL DISEASE;
NEUTROPENIA;
PATIENT MONITORING;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
RISK BENEFIT ANALYSIS;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
AGRANULOCYTOSIS;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
MIDDLE AGED;
AGRANULOCYTOSIS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIPSYCHOTIC AGENTS;
BREAST NEOPLASMS;
CLOZAPINE;
DOXORUBICIN;
FEMALE;
HUMANS;
MIDDLE AGED;
NEUTROPENIA;
SCHIZOPHRENIA;
|
EID: 1442264396
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.161.1.175 Document Type: Letter |
Times cited : (18)
|
References (5)
|